Merck in-licenses Cubicin for Japan

By BC Staff | Mar 23, 2007 | 1:32 AM GMT

Cubist (CBST) granted MRK rights to develop and commercialize Cubicin daptomycin

Read the full 112 word article

How to gain access

Continue reading with a
two-week free trial.